Aller au contenu principal
Accès ouvert déclaré 2025 article

Sanqi Oral Solution Containing Serum Ameliorates C5b-9 Induced Podocyte Injury via the Endoplasmic Reticulum Stress/Unfolded Protein Response Dependent Pathway

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Sanqi oral solution (SQ), a traditional Chinese medicine that is mainly composed of Astragalus membranaceus and Panax notoginseng, has been widely used for alleviating idiopathic membranous nephropathy, but its underlying molecular mechanism remains unclear. This study aims to investigate the effects of SQ on C5b-9-induced podocyte injury and explore the underlying mechanisms. After receiving 7-day intragastric administration of SQ (6.3 mL/kg/day), blood was harvested from the abdominal aorta of mice to prepare SQ-containing serum. MPC-5 cells were stimulated by the C5b-9 complex to construct an in vitro model of podocyte injury. CCK-8, flow cytometry, and lactate dehydrogenase (LDH) assays were employed to evaluate the effect of SQ-containing serum on podocyte injury. Immunofluorescence staining was performed to investigate the intracellular reactive oxygen species (ROS) levels. Western blotting was conducted to detect the expression of synaptopodin and podocin and activation of the endoplasmic reticulum (ER) stress/unfolded protein response (UPR) pathway. SQ-containing serum markedly ameliorates the podocyte injury induced by C5b-9, as evidenced by the increased cell viability, upregulated expression level of synaptopodin and podocin, and reduced cell apoptosis and LDH activity in C5b-9-treated MPC-5 cells. Additionally, SQ-containing serum significantly suppresses ROS levels in injured podocytes. Mechanically, SQ-containing serum could significantly block C5b-9-induced intracellular activation of the ER stress/UPR pathway in podocytes. After introducing 4-PBA, an ER stress inhibitor, the protection of SQ-containing serum was hardly observed on C5b-9-treated MPC-5 cells. SQ-containing serum ameliorates podocyte injury by suppressing oxidative stress and intracellular activation of the ER stress/UPR pathway.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Sanqi Oral Solution Containing Serum Ameliorates C5b-9 Induced Podocyte Injury via the Endoplasmic Reticulum Stress/Unfolded Protein Response Dependent Pathway
Date Crossref
01/01/2026
Éditeur
Tohoku University Medical Press
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Shantou Central Hospital Department of Traditional Chinese Medicine pays non établi dans la notice
    Établissement de santé

Department of Traditional Chinese Medicine — Shantou Central Hospital.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pharmacological Effects of Natural CompoundsRenal Diseases and GlomerulopathiesMedicinal Plants and Bioactive Compounds

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.